Real-time enrollment status for this recurrent multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:35 AM UTC
| NCT Number | NCT06465316 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 26 participants |
| Active Locations | 14 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 30, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT06465316 is currently recruiting participants. This clinical trial study for recurrent multiple myeloma is actively seeking new participants at 14 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06465316 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06465316 was last updated 1 week ago (June 30, 2026). HelloStudys verifies this status automatically.